Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer

Background: Malnutrition and cachexia are common in patients with advanced pancreatic ductal adenocarcinoma (PDAC) and have a significant influence on the tolerance and response to treatments. If timely identified, malnourished PDAC patients could be treated to increase their capacity to complete the planned treatments and, therefore, possibly, improve their efficacy. Aims: The aim of this study is to assess the impact of nutritional status, pancreatic exocrine insufficiency (PEI), and other clinical factors on patient outcomes in patients with advanced PDAC. Methods: PAncreatic Cancer MAlnutrition and Pancreatic Exocrine INsufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer (PAC-MAIN) is an international multicenter prospective observational cohort study. The nutritional status will be determined by means of Mini-Nutritional Assessment score and laboratory blood tests. PEI will be defined by reduced fecal elastase levels. MAIN OUTCOME: adherence to planned chemotherapy in the first 12 weeks following the diagnosis, according to patients' baseline nutritional status and quantified and reported as "percent of standard chemotherapy dose delivered." SECONDARY OUTCOMES: rate of chemotherapy-related toxicity, progression-free survival, survival at 6 months, overall survival, quality of life, and the number of hospitalizations. ANALYSIS: chemotherapy dosing over the first 12 weeks of therapy (i.e., percent of chemotherapy received in the first 12 weeks, as defined above) will be compared between well-nourished and malnourished patients. SAMPLE SIZE: based on an expected percentage of chemotherapy delivered of 70% in well-nourished patients, with a type I error of 0.05 and a type II error of 0.20, a sample size of 93 patients per group will be required in case of a percentage difference of chemotherapy delivered of 20% between well-nourished and malnourished patients, 163 patients per group in case of a difference of 15% between the groups, and 356 patients per group in case of a 10% difference. Centers from Russia, Romania, Turkey, Spain, Serbia, and Italy will participate in the study upon Local Ethics Committee approval. Discussion: PAC-MAIN will provide insights into the role of malnutrition and PEI in the outcomes of PDAC. The study protocol was registered at clinicaltrials.gov as NCT04112836

Analysis of landrace cultivation in Europe: A means to support in situ conservation of crop diversity

During the last century, the progressive substitution of landraces with modern, high yielding varieties, led to a dramatic reduction of in situ conserved crop diversity in Europe. Nowadays there is limited and scattered information on where landraces are cultivated. To fill this gap and lay the groundwork for a regional landrace in situ conservation strategy, information on more than 19,335 geo-referenced landrace cultivation sites were collated from 14 European countries. According to collected data, landraces of 141 herbaceous and 48 tree species are cultivated across Europe: Italy (107 species), Greece (93), Portugal (45) and Spain (44) hold the highest numbers. Common bean, onion, tomato, potato and apple are the species of main interest in the covered countries. As from collected data, about 19.8% of landrace cultivation sites are in protected areas of the Natura 2000 network. We also got evidence that 16.7% and 19.3% of conservation varieties of agricultural species and vegetables are currently cultivated, respectively. Results of the GIS analysis allowed the identification of 1261 cells (25 km × 25 km) including all the cultivation sites, distributed across all European biogeographical regions. Data of this study constitute the largest ever produced database of in situ-maintained landraces and the first attempt to create an inventory for the entire Europe. The availability of such resource will serve for better planning of actions and development of policies to protect landraces and foster their use

Preparation of Carbon Molecular Sieve Membranes with Remarkable CO2/CH4 Selectivity for High-pressure Natural Gas Sweetening

Carbon hollow fiber membranes (CHFMs) were fabricated based on cellulose hollow fiber precursors spun from a cellulose/ionic liquid system. By a thermal treatment on the precursors using a preheating process before carbonization, the micropores of the prepared CHFMs were tightened and thus resulting in highly selective carbon molecular sieve (CMS) membranes. By increasing the drying temperature from RT to 140 ◦C, the cellulose hollow fiber precursors show a substantial shrinkage, which results in a reduction of average pore size of the derived CHFMs from 6 to 4.9 Å. Although the narrowed micropore size causes the decrease of gas diffusion coefficient, stronger resistance to the larger gas molecules, such as CH4, eventually results in an ultra-high CO2/ CH4 ideal selectivity of 917 tested at 2 bar for CHFM-140C due to the simultaneously enhanced diffusion and sorption selectivity. The CHFM-140C was further tested with a 10 mol%CO2/90 mol%CH4 mixed gas at 60 ◦C and feed pressure ranging from 10 to 50 bar. The obtained remarkable CO2/CH4 separation factor of 131 at 50 bar and good stability make these carbon membranes great potential candidates for CO2 removal from high- pressure natural gas.publishedVersio

Preparation of Carbon Molecular Sieve Membranes with Remarkable CO2/CH4 Selectivity for High-pressure Natural Gas Sweetening

Carbon hollow fiber membranes (CHFMs) were fabricated based on cellulose hollow fiber precursors spun from a cellulose/ionic liquid system. By a thermal treatment on the precursors using a preheating process before carbonization, the micropores of the prepared CHFMs were tightened and thus resulting in highly selective carbon molecular sieve (CMS) membranes. By increasing the drying temperature from RT to 140 ◦C, the cellulose hollow fiber precursors show a substantial shrinkage, which results in a reduction of average pore size of the derived CHFMs from 6 to 4.9 Å. Although the narrowed micropore size causes the decrease of gas diffusion coefficient, stronger resistance to the larger gas molecules, such as CH4, eventually results in an ultra-high CO2/ CH4 ideal selectivity of 917 tested at 2 bar for CHFM-140C due to the simultaneously enhanced diffusion and sorption selectivity. The CHFM-140C was further tested with a 10 mol%CO2/90 mol%CH4 mixed gas at 60 ◦C and feed pressure ranging from 10 to 50 bar. The obtained remarkable CO2/CH4 separation factor of 131 at 50 bar and good stability make these carbon membranes great potential candidates for CO2 removal from high- pressure natural gas

A novel fully-humanised 3D skin equivalent to model early melanoma invasion

Metastatic melanoma remains incurable, emphasizing the acute need for improved research models to investigate the underlying biologic mechanisms mediating tumor invasion and metastasis, and to develop more effective targeted therapies to improve clinical outcome. Available animal models of melanoma do not accurately reflect human disease and current in vitro human skin equivalent models incorporating melanoma cells are not fully representative of the human skin microenvironment. We have developed a robust and reproducible, fully humanized three-dimensional (3D) skin equivalent comprising a stratified, terminally differentiated epidermis and a dermal compartment consisting of fibroblast-generated extracellular matrix. Melanoma cells incorporated into the epidermis were able to invade through the basement membrane and into the dermis, mirroring early tumor invasion in vivo. Comparison of our novel 3D melanoma skin equivalent with melanoma in situ and metastatic melanoma indicates that this model accurately recreates features of disease pathology, making it a physiologically representative model of early radial and vertical growth-phase melanoma invasion